Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study

Journal of Human Hypertension volume 24, pages 519–524 (2010)Cite this article

Abstract

Type 2 diabetes mellitus (T2DM) and hypertension frequently occur together. We examined whether blood pressure (BP) levels predict 8-year incident diabetes. Participants were community-dwelling older adults who had BP measured twice and an oral glucose tolerance test at baseline and again 8.3 years later. At baseline, participants were classified as normotensive (systolic blood pressure (SBP) <120 mm Hg and diastolic blood pressure (DBP) <80 mm Hg; n=242); prehypertensive (SBP⩾120 and <140 mm Hg or DBP⩾80 and <90 mm Hg; n=426); or hypertensive (SBP⩾140 mm Hg or DBP⩾90 mm Hg or using anti-hypertensive medication; n=457). There were 1125 participants (mean age 66.0 years; 44.3% men) who attended the baseline and follow-up visit, of whom 85 had new onset T2DM. Participants who developed T2DM had higher mean body mass index (BMI) and BP levels than those who did not develop diabetes. In logistic regression models adjusted for age, sex, BMI, and physical activity, the odds of incident T2DM was greater in prehypertensives (odds ratio (OR) 2.32 95% confidence interval (CI) 1.05–5.1, P=0.03) and hypertensives (OR 3.5 95% CI 1.50–8.0, P=0.002) compared with normotensives. Excluding participants who used anti-hypertensive medications did not change results. In conclusion, mid-life hypertension and prehypertension predicted future diabetes, independent of BMI. Glucose surveillance should be encouraged in adults with prehypertension or hypertension.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  2. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Article  Google Scholar 

  3. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ . Blood pressure and risk of developing type 2 diabetes mellitus: the Women′s Health Study. Eur Heart J 2007; 28: 2937–2943.

    Article  Google Scholar 

  4. Meisinger C, Doring A, Heier M . Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the monitoring trends and determinants on cardiovascular diseases/cooperative health research in the Region of Augsburg cohort study. J Hypertens 2008; 26: 1809–1815.

    Article  CAS  Google Scholar 

  5. Barrett-Connor E . The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 1980; 111: 705–712.

    Article  CAS  Google Scholar 

  6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 (Suppl 1): S62–S67.

  7. Hypertension detection and follow-up group. The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group. Prev Med 1976; 5: 207–215.

  8. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  Google Scholar 

  9. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.

    Article  CAS  Google Scholar 

  10. Izzo R, de Simone G, Chinali M, Iaccarino G, Trimarco V, Rozza F et al. Insufficient control of blood pressure and incident diabetes. Diabetes Care 2009; 32: 845–850.

    Article  Google Scholar 

  11. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–357.

    Article  CAS  Google Scholar 

  12. DeFronzo RA, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194.

    Article  CAS  Google Scholar 

  13. Asch S, Wingard DL, Barrett-Connor EL . Are insulin and hypertension independently related? Ann Epidemiol 1991; 1: 231–244.

    Article  CAS  Google Scholar 

  14. Anneren C, Welsh M, Jansson L . Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter. Am J Physiol Endocrinol Metab 2007; 292: E1183–E1190.

    Article  CAS  Google Scholar 

  15. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 2007; 56: 1898–1904.

    Article  CAS  Google Scholar 

  16. Meigs JB, Hu FB, Rifai N, Manson JE . Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978–1986.

    Article  CAS  Google Scholar 

  17. Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J et al. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens 2009; 23: 176–181.

    Article  CAS  Google Scholar 

  18. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R et al. Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 2002; 51: 1986–1988.

    Article  CAS  Google Scholar 

  19. Stephens JW, Dhamrait SS, Cooper JA, Acharya J, Miller GJ, Hurel SJ et al. The D allele of the ACE I/D common gene variant is associated with Type 2 diabetes mellitus in Caucasian subjects. Mol Genet Metab 2005; 84: 83–89.

    Article  CAS  Google Scholar 

  20. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY . Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med 2008; 263: 376–385.

    Article  CAS  Google Scholar 

  21. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY . Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J Hypertens 2008; 26: 1780–1786.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The Rancho Bernardo Study was funded by the National Institutes of Health/National Institute on Aging grant AG07181 and grant AG028507 and the National Institute of Diabetes and Digestive and Kidney Diseases, grant DK31801. CKK was a recipient of a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazil (Programa de Doutorado no Pais com Estagio no Exterior [PDEE] sandwich).

Author information

Authors and Affiliations

  1. Division of Epidemiology, Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA,

    C K Kramer, D von Mühlen & E Barrett-Connor

  2. Division of Endocrinology, Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil,

    C K Kramer

Authors
  1. C K Kramer
    View author publications

    Search author on:PubMed Google Scholar

  2. D von Mühlen
    View author publications

    Search author on:PubMed Google Scholar

  3. E Barrett-Connor
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to E Barrett-Connor.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kramer, C., Mühlen, D. & Barrett-Connor, E. Mid-life blood pressure levels and the 8-year incidence of type 2 diabetes mellitus: the Rancho Bernardo Study. J Hum Hypertens 24, 519–524 (2010). https://doi.org/10.1038/jhh.2009.103

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2009.103

Keywords

This article is cited by

Search

Advanced search

Quick links